Page last updated: 2024-09-04

olmesartan and bepridil

olmesartan has been researched along with bepridil in 2 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (bepridil)	Trials (bepridil)	Recent Studies (post-2010) (bepridil)
841	185	554	798	70	94

Protein Interaction Comparison

Protein	Taxonomy	bepridil (IC50)
Voltage-dependent L-type calcium channel subunit alpha-1C	Cavia porcellus (domestic guinea pig)	1.4
Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens (human)	1
Lethal factor	Bacillus anthracis	4.8
Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens (human)	1
Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)	0.5184
Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens (human)	1
Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens (human)	1.2
Sodium channel protein type 5 subunit alpha	Homo sapiens (human)	3.7

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Fukaya, H; Hirasawa, S; Izumi, T; Kiryu, M; Masaki, Y; Moriguchi, M; Niwano, H; Niwano, S; Sato, D	1

Other Studies

2 other study(ies) available for olmesartan and bepridil

Article	Year
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model. International journal of cardiology, 2012, May-31, Volume: 157, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Disease Models, Animal; Dogs; Down-Regulation; Drug Therapy, Combination; Heart Conduction System; Imidazoles; Tetrazoles; Up-Regulation	2012

Article

Year

Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013

Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model.

International journal of cardiology, 2012, May-31, Volume: 157, Issue:2

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Disease Models, Animal; Dogs; Down-Regulation; Drug Therapy, Combination; Heart Conduction System; Imidazoles; Tetrazoles; Up-Regulation

2012